Nootropics

Modafinil

Evidence: strong_human

Mechanism of Action

Atypical eugeroic (wakefulness-promoting agent) that primarily inhibits the dopamine transporter (DAT), increasing extracellular dopamine in the prefrontal cortex and nucleus accumbens. This primary action cascades through multiple systems: indirect activation of orexinergic neurons in the lateral hypothalamus via potentiation of glutamatergic transmission; downstream stimulation of histaminergic neurons in the tuberomammillary nucleus (via orexin-mediated disinhibition of GABAergic inputs); and enhancement of norepinephrine release in the locus coeruleus. The net effect is broad-spectrum arousal without the peripheral sympathomimetic effects of classical stimulants.

Dosing Protocol

Standard: 100-200 mg once daily (for educational context only — prescription medication in most jurisdictions)

Maintenance: 100-200 mg/day

Administration: oral

Timing: Early morning to avoid insomnia; 1 hour before desired peak alertness. With or without food (food slows absorption by ~1 hour but does not reduce bioavailability). Half-life is approximately 12-15 hours.

Duration: Not typically cycled in clinical use. Some off-label users cycle to maintain sensitivity (5 days on, 2 off; or as-needed use).

Notes

FOR EDUCATIONAL PURPOSES ONLY — Modafinil is a prescription medication in most countries. The Battleday & Brem 2015 systematic review found that modafinil consistently enhances executive function, attention, and learning in non-sleep-deprived healthy subjects, particularly on more complex tasks. It has lower abuse potential than amphetamines but is not zero-risk. The CYP3A4 induction effect on oral contraceptives is clinically critical and under-communicated. Stevens-Johnson syndrome is rare but life-threatening — any skin rash warrants immediate discontinuation. Tolerance development is minimal compared to classical stimulants. Many users report that effects plateau and do not escalate with dose increases beyond 200mg.

Stacking

  • L-Theanine (to reduce overstimulation)
  • Alpha-GPC
  • Magnesium (to mitigate jaw tension)

Interactions

  • Hormonal contraceptives [HIGH] — Modafinil induces CYP3A4, reducing efficacy of oral contraceptives — use alternative contraception
  • Cyclosporine [HIGH] — CYP3A4 induction reduces cyclosporine blood levels; organ rejection risk
  • CYP2C19 substrates (Omeprazole, Diazepam, Phenytoin) [MEDIUM] — Modafinil inhibits CYP2C19; may increase plasma levels of these drugs
  • MAOIs [MEDIUM] — Caution due to combined monoaminergic effects
  • Warfarin [MEDIUM] — Monitor INR; modafinil may alter warfarin metabolism

Contraindications

  • Mitral valve prolapse or left ventricular hypertrophy
  • Severe hepatic impairment
  • Severe anxiety or psychotic disorders
  • History of substance abuse (mild abuse potential)
  • Hypersensitivity to modafinil or armodafinil
  • Pregnancy (Category C)

Side Effects

  • Headache (most common)
  • Nausea
  • Anxiety/nervousness
  • Insomnia
  • Dry mouth
  • Dizziness
  • Upper respiratory tract infection
  • Diarrhea
  • Stevens-Johnson syndrome (very rare but serious)

Key Papers

  • 10.1016/j.euroneuro.2015.07.028
  • 10.1038/1301534
  • 10.1177/0269881108092123

Source Quality

Prescription medication (Schedule IV in the US, Prescription Only Medicine in the UK/EU/Australia). Pharmaceutical brands include Provigil (Cephalon/Teva), Modalert (Sun Pharma), and Modvigil (HAB Pharma). Underground/grey-market sourcing carries risks of counterfeit or contaminated product. Pharmaceutical-grade only — do not use research chemical sources for this compound.

Disclaimer: This information is for educational purposes only and is not medical advice. BioAccelera Labs does not diagnose, treat, or prescribe. Consult a licensed healthcare provider before using any compound.

Should Modafinil Be in Your Stack?

Take the free assessment and get personalized recommendations based on your biology and goals.

Get Your Free Protocolor take the assessment →
← Browse All 231 Compounds